Nurses Needed Now
A nursing shortage is hammering hospitals everywhere. Nursing leader Gina Intinarelli-Shuler, PhD ’13, RN, shares how UCSF is handling the challenge.
University of California San Francisco
Give to UCSF
Get Back in the Game
UCSF sports medicine experts share their savvy on how to overcome injuries and stay active for life.
Training the Eye to See Disease On Dark Skin
Most dermatologists aren’t adequately taught to treat patients of color. UCSF’s Jenna Lester wants to fix that.
Preparing for a Post-Roe America
What happens once abortion is illegal in half the country?
The Nobel-Winning Discoveries Illuminating How We Sense the World
How David Julius and Ardem Patapoutian found the molecules in our bodies that sense heat, cold, touch, and pain – and transformed sensory neuroscience.
UCSF to Return to Golden Gate Park to Raise Funds in AIDS Walk San Francisco
After two years of participating in mostly virtual events due to the pandemic, UCSF is rallying its community to come together in Golden Gate Park for AIDS Walk San Francisco on July 17 to raise funds for programs and services that benefit people of the Bay Area.
Amid Global Shortage, Study Shows How to Cut Contrast Dye Use 83%
As a worldwide shortage of contrast dye for medical imaging continues, a new UCSF research letter in JAMA quantified strategies to safely reduce dye use in computed tomography (CT) by up to 83%. CT is the most common use for the dye.
Some Patients with Lung Disease Fare Worse Than Others. Could Sleep Explain It?
A study led by UCSF researchers shows that insufficient or interrupted sleep may have more of an impact than smoking history in patients with a progressive lung disease.
Hospice Improves Quality of Care in Patients With Dementia
A new study by researchers at UCSF and Icahn School of Medicine at Mount Sinai shows that hospice patients with dementia are more likely to receive excellent care and have their anxiety and sadness managed than those not on hospice.
New Biomarker Classifications May Improve Treatment for High-Risk Breast Cancer Patients
UCSF research scientists and statisticians have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients. The new cancer response subtypes reflect responsiveness to drug treatments and are intended to help clinicians be more precise in how they target therapies.
